Photo Credit; Getty Images

The world’s largest condom manufacturer, Karex, is preparing to significantly increase its prices as global supply chains continue to feel the strain of the ongoing conflict involving Iran. According to the company’s chief executive, Goh Miah Kiat, prices could rise by as much as 30 percent or even higher if disruptions persist.

Karex, which produces more than five billion condoms annually, supplies major international brands such as Durex and Trojan, as well as public health systems including the United Kingdom’s NHS. This makes the company a critical player in global sexual health supply chains. Any change in its pricing has wide reaching implications for both consumers and public health programs.

The rising costs are closely tied to disruptions in global energy markets. Since Iran responded to military actions by the United States and Israel with threats targeting shipping routes, the Strait of Hormuz has effectively been compromised. This narrow passage is vital to global trade, with roughly one fifth of the world’s crude oil and liquefied natural gas passing through it under normal conditions.

As shipments slow and costs rise, industries that depend on petroleum based materials are facing increasing pressure. Karex is one such company. Its production relies heavily on oil derived inputs, including ammonia used in latex preservation and silicone based lubricants. As oil prices and transport costs climb, so too does the cost of manufacturing condoms.

Goh noted that production expenses have risen sharply since the conflict began. At the same time, demand for condoms has surged by around 30 percent this year. This increase is partly driven by economic uncertainty, with more people seeking to avoid unplanned pregnancies during unstable times. Goh explained that in uncertain conditions, individuals become more cautious about their financial future, making family planning even more important.

The impact of the conflict is not limited to the condom industry. Rising fuel prices and disrupted shipping routes are pushing up costs across a wide range of sectors. Air travel has become more expensive, with economy ticket prices rising significantly compared to last year. Fertiliser costs are also increasing, which could have long term effects on food production. In addition, shortages of helium, a key component in semiconductor manufacturing, are beginning to affect the technology sector.

Photo Credit: Getty Images

Novo Nordisk, the maker of the diabetes and weight-loss drug Ozempic, is facing mounting legal pressure as more than 2,000 people have filed lawsuits alleging the drug caused serious, life-altering health complications. The combined damages being sought are estimated to exceed $2 billion, making the case one of the largest pharmaceutical lawsuits in recent years.

Photo Credit; Getty Images

Just days after OpenAI’s entry into the space, Anthropic has unveiled healthcare features for Claude that allow the AI to access and analyze sensitive medical records. While this signals a major technological push into life sciences, the move highlights the growing role of AI in high-stakes fields where accuracy and privacy are paramount. The launch positions healthcare as the ultimate testing ground for whether generative AI can safely handle the world's most personal data.

Both tools will allow users to share information from health records and fitness apps, including Apple’s Health app, to personalize health-related conversations.

At the same time, the expansion comes amid heightened scrutiny over whether AI systems can safely interpret medical information and avoid offering harmful guidance.

Photo Credit: Getty Images
 
In Istanbul, patients at private hospitals are witnessing an unusual blend of ancient tradition and modern medicine. Therapies once confined to informal settings, such as wet cupping and leech treatments, are increasingly being offered in clinical environments under strict regulation. Known locally as hacamat, wet cupping is among the practices now embraced by certified medical professionals.

 

Photo Credit; Getty Images

OpenAI has introduced a health-focused feature in the U.S. designed to provide personalized advice by analyzing users' medical records and data from fitness apps like MyFitnessPal. While the company emphasized that "Chat Health" data is stored separately and not used to train its AI models, the launch has sparked warnings from privacy campaigners. OpenAI also clarified that the tool is strictly for informational purposes and is not intended to provide professional medical "diagnosis or treatment.”

Photo Credit: Getty Images
 
A groundbreaking medical innovation may soon change the way heart disease is detected and treated. Researchers in the United Kingdom have revealed that stethoscopes powered by artificial intelligence can diagnose serious conditions in mere seconds. These conditions include heart failure, valve disease, and abnormal rhythms, all of which can go undetected until severe symptoms emerge.

Photo Credit: Getty Images

The Maldives has implemented a groundbreaking nationwide generational tobacco prohibition, banning anyone born on or after January 1, 2007, from smoking tobacco. The archipelago's health ministry announced on Saturday that it would be illegal for these younger generations to use, buy, or sell tobacco within the country. This initiative makes the Maldives the only nation globally to enforce such a comprehensive measure, reflecting the government's "strong commitment to protecting young people from the harms of tobacco," the ministry stated.

Photo Credit: Getty Images
 
Pharmaceutical research firms in China are increasingly turning to domestically produced reagents, signaling a potential long-term shift away from reliance on Western suppliers. Rising tariffs on U.S. goods, cost considerations, and supply chain efficiency are driving this trend, according to industry executives.

RECENT NEWS

LATEST JOB OFFERS

AROUND THE CITIES